
Opsis Therapeutics
Opsis Therapeutics
Retinal degenerative diseases cause irreversible vision loss in tens of millions of patients worldwide. Our mission at Opsis Therapeutics is to advance a pipeline of first-in-class cell replacement therapies targeting Age-Related Macular Degeneration (AMD) and a broad range of inherited retinal disorders including Retinitis Pigmentosa. Opsis technology platform builds upon recent advances that enable scalable manufacture of authentic human retinal cells from induced-pluripotent stem cells.
Company details
Find locations served, office locations.
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2016